Literature DB >> 2298734

The mechanism of carbohydrate-mediated complement activation by the serum mannan-binding protein.

M Ohta1, M Okada, I Yamashina, T Kawasaki.   

Abstract

Serum mannan-binding protein (S-MBP), a lectin specific for mannose and N-acetylglucosamine, was documented to activate complement through the classical pathway. In this study, we examined the mechanism that initiates this activation. By a passive hemolysis test using sheep erythrocytes coated with yeast mannan, the activation of complement by human S-MBP was shown to proceed in the absence of C1q. The following binding studies using 125I-labeled C1r2s2 and C1s indicated that the activated form of C1r2s2 bound to S-MBP located on the surface of the cells with high affinity. The binding of C1s to the cell-bound S-MBP require the presence of C1r, suggesting that C1r2s2 binds to S-MBP through C1r. The activation of C1s from a proenzyme to a protease was mediated by cell-bound S-MBP in the presence of C1r and the activated protease remained associated with the cells and was not released into the medium. The activation of complement with S-MBP was a solid phase event and did not proceed in a fluid phase. On the basis of these results, it was concluded that S-MBP is responsible for the initiation of carbohydrate-mediated complement activation as C1q does in immune complex-mediated complement activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298734

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity.

Authors:  Y Ma; K Uemura; S Oka; Y Kozutsumi; N Kawasaki; T Kawasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 3.  Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems.

Authors:  Wendell F Rosse; Junichi Nishimura
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

4.  Plasma factor triggering alternative complement pathway activation by liposomes.

Authors:  K Funato; C Yamashita; J Kamada; S Tominaga; H Kiwada
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

5.  Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans.

Authors:  M Ohta; T Kawasaki
Journal:  Glycoconj J       Date:  1994-08       Impact factor: 2.916

6.  A study of novel lectins and their involvement in the activation of the prophenoloxidase system in Blaberus discoidalis.

Authors:  C Chen; H J Durrant; R P Newton; N A Ratcliffe
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation.

Authors:  G Z Jiang; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype.

Authors:  R J Lipscombe; M Sumiya; J A Summerfield; M W Turner
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

9.  Novel adjuvant action of lipopolysaccharides that possess mannose homopolysaccharides as O-specific polysaccharides on immune responses to nonimmunogenic autoantigens in mice.

Authors:  T Yokochi; M Fukada; M Kawai; Y H Zhang; G Z Jiang; K Takahashi
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum.

Authors:  I Terai; K Kobayashi; M Matsushita; T Fujita
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.